WCY-8-67
WCY-8-67 is an orally active and selective USP5 inhibitor, with an IC50 value of 1.33 μM. WCY-8-67 induces apoptosis and suppresses JAK/STAT3 and PI3K/AKT signaling pathways in vitro. WCY-8-67 inhibits proliferation of AE-positive AML cells, induces G1 phase arrest and differentiation of AML cells. WCY-8-67 demonstrates potent anti-leukemic efficacy in mice. WCY-8-67 can be used for the study of acute myeloid leukemia[1].
Product Specifications
CAS Number
3052618-54-6
UNSPSC
12352005
Target
Akt; Apoptosis; Deubiquitinase; JAK; PI3K; STAT
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; JAK/STAT Signaling; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Smiles
CN(C)CCN(C1=C2C(CN(C3=C4C=CC=CC4=C(F)C=C3)C2)=NC(N5CCNCC5)=N1)C
Molecular Formula
C25H32FN7
Molecular Weight
449.57
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2741), CF640R conjugate, 0.1mg/mL
PCNA (Proliferating Cell Nuclear Antigen) (G1- & S-phase Marker) (PC5), CF740 conjugate, 0.1mg/mL
AIF1 / Iba1 (Microglia Marker) (AIF1/1909), CF594 conjugate, 0.1mg/mL
![LRATD2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI10A2]](https://cdn.genprice.uk/products/937/6868c333994c49e6dc3f126c/imageurl/ta501920am.webp)
LRATD2 Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI10A2]
